The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
VTGN · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | ONCO | STEX | VTGN | CODX |
|---|---|---|---|---|
| Moat Score (0–100) | 34 | 35 (highest) | 34 | 34 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 50 (highest) | 30 | 38 | 10 |
| Pricing power | 42 | 71 | — | 74 (highest) |
| Returns on capital | 0 | 0 | 0 | 8 (highest) |
| Balance-sheet safety | 28 | 28 | 55 (highest) | 55 (highest) |
| Capital allocation | 53 (highest) | 44 | 44 | 24 |
| No price data | No price data | No price data | No price data | |
| Market cap | $1.3M | $36.7M | $9.3M | $63 |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2026 | FY2025 |